Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005

Cancer

Volumn 115, Issue 21, 2009, Pages 4973-4979

  Pulte, Dianne ^a,b   Gondos, Adam ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Adolescence; Leukemia; Lymphoma; Period analysis; Survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC TEST; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; UNITED STATES;

ADOLESCENT; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 70350503161     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24548     Document Type: Article

References (28)

1. Bleyer A, O'Leary M, Barr R, Ries L. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2006.
2. Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer. 1996;78:2004-2010. (Pubitemid 26360586)
3. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer. 2004;40:326-335.
4. Surveillance, Epidemiology, and End Results (SEER) Program Limited Use Data (1973-2005). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2008.
5. Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol. 2006;164:689-696. (Pubitemid 44453498)
6. Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol. 2002;20:826-832. (Pubitemid 34111392)
7. Brenner H, Soderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol. 2002;31:456-462. (Pubitemid 34537812)
8. Brenner H. Up-to-date survival curves of children with cancer by period analysis. Br J Cancer. 2003;88:1693-1697. (Pubitemid 36760411)
9. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6: 101-121.
10. Henson DE, Ries LA. The relative survival rate. Cancer. 1995;76:1687-1688.
11. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10. Bethesda, MD: National Cancer Institute; 1959.
12. Arias E. United States life tables, 2000. Natl Vital Stat Rep. 2002;51(3):1-38.
13. Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002;38:1-10.
14. Gatta G, Capocaccia R, De Angelis R, Stiller C, Coebergh JW. Cancer survival in European adolescents and young adults. Eur J Cancer. 2003;39:2600-2610. (Pubitemid 37468301)
15. Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst. 2008;100:1301-1309.
16. Cairo MS, Raetz E, Lim MS, Davenport V, Perkins SL. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future. Pediatr Blood Cancer. 2005;45:753-769. (Pubitemid 41416485)
17. Center for Disease Control and Prevention. HIV Statistics and Surveillance: Basic Statistics. Available at: http://www. cdc.gov/hiv/topics/ surveillance/basic.htm#data Accessed on July 15, 2008.
18. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187-194. (Pubitemid 351705208)
19. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288-298.
20. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112:1646-1654.
21. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003;21:774-780.
22. Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer. 2007;48:254-261.
23. Hallboeoek H, Gustafsson G, Smedmyr B, et al. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer. 2006;107:1551-1561. (Pubitemid 44546916)
24. Ribera JM, Oriol A, Sanz MA, et al. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96. J Clin Oncol. 2008;26:1843-1849.
25. Collins SR, Schoen C, Kriss JL, Doty MM, Mahato B. Rite of passage? Why young adults become uninsured and how new policies can help. Issue Brief (Commonw Fund). 2007;26:1-16.
26. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007;12:816-824. (Pubitemid 47328225)
27. Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica. 2008;93:594-600.
28. Zuccolo L, Dama E, Maule MM, Pastore G, Merletti F, Magnani C. Updating long-term childhood cancer survival trend with period and mixed analysis: good news from population- based estimates in Italy. Eur J Cancer. 2006;42:1135-1142.